Why the study?
Postprocedural ischaemic and bleeding risks after TAVR remain a major concern, but no reliable risk models incorporating both outcomes are currently available.
Do PCI-derived risk models (PARIS and CREDO-Kyoto) accurately predict 1-year ischemic and bleeding risks in Japanese TAVR patients?
Do PCI-derived risk models (PARIS and CREDO-Kyoto) accurately predict 1-year ischemic and bleeding risks in Japanese TAVR patients?
PCI-derived risk models like PARIS and CREDO-Kyoto demonstrate inadequate accuracy for predicting 1-year ischemic and bleeding events in TAVR patients, even after recalibration.
Answers are grounded in this paper and cite their sources.
PCI-derived models may inadequately predict post-TAVR risks; TAVR-specific recalibration leaves open need for prospective validation.
OBJECTIVE: Postprocedural ischaemic and bleeding risks after transcatheter aortic valve replacement (TAVR) remain a major concern. Nevertheless, no reliable risk models incorporating both possibilities are currently available. We aimed to assess the accuracy of percutaneous coronary intervention (PCI)-derived models and the performance of a recalibrated model that included variables more applicable to TAVR. METHODS: This study included 26 869 patients who had been enrolled in a national registry. Ischaemic events were defined as myocardial infarction, stroke, transient ischaemic attack or peripheral embolism at 1 year. Bleeding events were defined as any bleeding based on the Valve Academic Research Consortium-2 consensus document at 1 year. Patterns of Non-adherence to Anti-Platelet Regimen in Stented Patients (PARIS) and Coronary Revascularisation Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) integer scoring systems were tested. The models were recalibrated by applying new variables using the Fine and Gray method. RESULTS: The 1-year cumulative incidences for ischaemic and bleeding events were 2.7% and 3.1%. Patients with high PARIS and CREDO-Kyoto risk scores had higher incidences of both ischaemic (3.3% vs 2.4% vs 2.4%, p<0.001 and 2.8% vs 2.0% vs 0.8%, p<0.001) and bleeding events (3.3% vs 2.5% vs 0.8%, p<0.001 and 3.7% vs 3.0% vs 2.4%, p<0.001) when compared with intermediate and low-risk patients. The receiver operating characteristic area under the curves for these models were 0.53, 0.58, 0.56 and 0.55, respectively. After the models were recalibrated to incorporate variables more applicable to TAVR, the performance of ischaemic and bleeding models modestly improved (0.58 and 0.61, respectively). CONCLUSIONS: The PCI-derived models demonstrated modest accuracy but was inadequate for risk stratification of TAVR patients at 1-year follow-up. TRIAL REGISTRATION NUMBER: 3395.
No takes yet. Share an insight, caveat, or question.
Ohya et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: